drugset / Trial / NCT02736695
Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia
Phase 1
Completed
81 enrolled
Mayo Clinic
National Institute of Neurological Disorders and Stroke (NINDS) · collab
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
This study is designed to learn more about overall tau burden in the brain of patients with Primary Progressive Aphasia (PPA) and Frontotemporal Dementia.
Timeline
- Start
- 2016-07
- Primary completion
- 2024-08-01
- Completion
- 2024-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flortaucipir F18 | Diagnostic / imaging agent | — | — |